MOVING FORWARD
The group strategy is concentrated on further expansion and growth, with a particular focus on :
- Further international expansion of Newton 21 and Vivactis with a particular focus on Eastern and Central Europe and BRIC countries. These markets have not yet reached maturity or saturation, and show impressive growth.
- Development of the Vivactis brand in healthcare communications and marketing by:
- Further geographic expansion and...
- Diversification of the healthcare communications and marketing services of the group, focusing on market niches that require cross-disciplinary expertise. In addition to our traditional advertising, communications and consultancy service, this involves offering ourselves within the fields of (but not limited to) clinical trials, medical education, multimedia and nutrition.
- Investment in digital communication - branching out into new digital specialisations and anticipating market trends.
- Increasing the Newton 21 group portfolio of truly international clients, served by several geographic markets.